Skip to content
Clinical Trials – home

Pneumonia bacterial Basic Information

7 / 10 trials open to patients12 countries

In short

Bacterial pneumonia is an infection of the lungs caused by harmful bacteria that triggers inflammation and fluid buildup in the air sacs, making it difficult to breathe. While this condition can affect anyone, it poses the greatest risk to young children, older adults, and people with weakened immune systems or chronic health conditions.

Key points

  • Bacterial pneumonia fills the air sacs in your lungs with fluid and pus, making breathing difficult and preventing oxygen from reaching your bloodstream efficiently
  • The most common cause is Streptococcus pneumoniae bacteria, though many other bacteria can trigger the infection depending on where and how you were exposed
  • More than 41,000 Americans died from pneumonia in 2022, with children under five and adults over 65 facing the highest risks
  • The color of mucus you cough up can provide important clues about which bacteria is causing your pneumonia—rust-colored, green, or red jelly-like sputum each point to different bacterial culprits
  • Two vaccines specifically protect against the most common bacterial cause of pneumonia, and staying current with flu and COVID-19 vaccines also helps prevent secondary bacterial infections
  • Recovery can take anywhere from one week for mild cases to six months for severe pneumonia requiring hospitalization, with fatigue often lingering long after the infection clears
  • Completing the entire course of antibiotics is critical—stopping early allows resistant bacteria to survive and multiply, potentially causing relapse and making treatment harder
  • Smoking dramatically increases pneumonia risk by damaging the lungs' natural defense mechanisms, making quitting one of the most effective prevention strategies available

Understanding Bacterial Pneumonia

Bacterial pneumonia occurs when disease-causing bacteria invade the lungs and multiply within the tissue and air spaces. The ancient Greek word "pneumon" means "lung," so pneumonia essentially translates to "lung disease." When bacteria enter the respiratory system, they trigger a complex response from the body's immune system—the network of cells and proteins that defends against infections. This response causes the tiny air sacs in the lungs, called alveoli, to become inflamed and fill with fluid or pus, which interferes with normal breathing and oxygen exchange.

Under normal circumstances, many bacteria can live harmlessly in the throat without causing any problems. However, when the body's defenses become weakened for any reason, these bacteria can travel down into the lungs and cause infection. The air sacs become swollen and congested with fluid, making it harder for oxygen to pass from the lungs into the bloodstream. This is why people with bacterial pneumonia often feel short of breath and may appear pale or bluish around the lips and fingertips.

Epidemiology: Who Gets Bacterial Pneumonia

Bacterial pneumonia has a significant impact on public health worldwide, contributing substantially to illness and death rates across all age groups. In the United States, pneumonia is the second most common reason for hospital admission among both children and adults. According to data from the Centers for Disease Control and Prevention, more than 41,000 people died from pneumonia in the United States during 2022 alone.

The disease affects people of all ages, but certain groups face considerably higher risks. Children younger than five years old are particularly vulnerable, with pneumonia representing the leading cause of death in this age group globally. In 2019, pneumonia killed more than 740,000 children under five worldwide—more deaths than from HIV, malaria, or tuberculosis. Among adults, the incidence of community-acquired pneumonia—pneumonia contracted outside of healthcare facilities—is approximately 14 cases per 1,000 people per year, with more than half of these cases requiring hospitalization.

Age plays a crucial role in pneumonia risk. Older adults, particularly those over 65 years of age, face increased susceptibility and more severe outcomes. Similarly, infants and very young children have developing immune systems that make them more vulnerable to serious bacterial infections. The economic burden is also substantial, with community-acquired pneumonia estimated to cost more than 10 billion euros annually in Europe alone, accounting for medical expenses and lost productivity.

What Causes Bacterial Pneumonia

The most common bacterial cause of pneumonia is Streptococcus pneumoniae, also known as pneumococcus. This bacterium is responsible for the majority of community-acquired bacterial pneumonia cases. Pneumococcal disease can also cause other infections such as ear infections, sinus infections, and meningitis. Other important bacterial causes include Mycoplasma pneumoniae, which typically causes a milder form of pneumonia sometimes called "atypical pneumonia," as well as Haemophilus influenzae, Chlamydia pneumoniae, and Legionella, which causes Legionnaires' disease.

The type of bacteria that causes pneumonia can vary depending on where the infection is acquired. When pneumonia develops outside of healthcare settings, it is classified as community-acquired pneumonia. However, people can also develop hospital-acquired pneumonia, which occurs 48 hours or more after admission to a hospital. This type is usually more serious because it is often caused by antibiotic-resistant bacteria, such as methicillin-resistant Staphylococcus aureus, commonly known as MRSA. These resistant bacteria are harder to treat and can make patients much sicker.

Another important category is aspiration pneumonia, which happens when solid food, liquids, saliva, or vomit accidentally go down the windpipe and into the lungs instead of the esophagus. If these materials cannot be coughed up, the lungs can become infected with bacteria that normally live in the mouth and throat.

Risk Factors for Bacterial Pneumonia

Several factors increase the likelihood of developing bacterial pneumonia. Age is one of the most significant risk factors. People who are 65 years or older have weaker immune systems and often have other health conditions that make them more susceptible to infections. At the other end of the spectrum, children under five years old, especially infants, are also at heightened risk because their immune systems are still developing.

Chronic medical conditions significantly increase pneumonia risk. People with asthma, diabetes, heart disease, or chronic obstructive pulmonary disease are more vulnerable to bacterial lung infections. Those recovering from surgery may also be at increased risk because surgery and anesthesia can temporarily weaken the body's defenses. Poor nutrition and inadequate intake of vitamins and minerals can compromise immune function, making it easier for bacteria to cause infection.

Lifestyle factors play an important role as well. Smoking damages the lungs' natural defense mechanisms, making it easier for bacteria to establish infection and harder for the body to clear them out. Excessive alcohol consumption weakens the immune system and can impair the cough reflex, which is important for clearing secretions from the airways. People who have recently had viral pneumonia, such as from influenza or COVID-19, are at increased risk of developing secondary bacterial pneumonia because the viral infection weakens the respiratory system and allows bacteria to thrive.

Individuals with compromised immune systems face particularly high risk. This includes people who have recently undergone organ transplantation, those who are HIV positive, and patients with leukemia, lymphoma, or severe kidney disease. These conditions or their treatments suppress the immune system, reducing the body's ability to fight off bacterial invaders.

Recognizing the Symptoms

The symptoms of bacterial pneumonia can appear suddenly and be quite intense, or they may develop more gradually over several days. The most consistent and common symptom is a cough that produces sputum—thick mucus from the lungs. The color and appearance of this mucus can sometimes provide clues about the cause. Streptococcus pneumoniae often produces rust-colored sputum, while infections with Pseudomonas, Haemophilus, or other pneumococcal species may produce greenish sputum. Klebsiella pneumonia characteristically produces thick, blood-tinged sputum that resembles red currant jelly. When anaerobic bacteria are involved, the sputum often has a foul smell or bad taste.

Fever is another hallmark symptom, with body temperature often rising to 105 degrees Fahrenheit or higher in bacterial pneumonia. However, some patients, particularly older adults, may have a lower-than-normal body temperature instead of a fever. Chills severe enough to cause shaking often accompany the fever. Many patients experience sharp or stabbing chest pain that worsens when breathing deeply or coughing. This pain occurs because the infection causes inflammation of the tissues surrounding the lungs.

Breathing difficulties are common and can range from mild shortness of breath to severe respiratory distress. People with bacterial pneumonia often feel they cannot catch their breath, especially when moving around or exerting themselves. The breathing rate may increase noticeably, and patients may use their shoulder and neck muscles to help them breathe—something that does not normally happen with regular breathing.

General symptoms include profound fatigue and feeling extremely tired, loss of appetite, excessive sweating, and rapid heartbeat. Some people also experience nausea, vomiting, or diarrhea. When oxygen levels in the blood drop too low, the lips and fingernails may take on a bluish tint, a condition called cyanosis. In older adults, pneumonia can cause confusion or changes in mental awareness rather than the typical fever and cough. This altered mental state is an important warning sign that should not be ignored.

Prevention Strategies

Preventing bacterial pneumonia involves both vaccination and healthy lifestyle practices. Two types of vaccines specifically protect against pneumococcal disease, the most common bacterial cause of pneumonia. The PCV13 vaccine (Prevnar 13) is recommended for people 65 years or older, children under five years, and anyone with a high risk of bacterial pneumonia. The PPSV23 vaccine (Pneumovax) is recommended for people 65 and older, children over two who are at high risk, and adults between 19 and 64 who smoke or have asthma.

Other vaccines also help prevent pneumonia indirectly by protecting against infections that can lead to pneumonia or weaken the respiratory system. Annual influenza vaccination is important because flu can lead to pneumonia as a complication. COVID-19 vaccines help prevent coronavirus infection, which can cause viral pneumonia and increase the risk of secondary bacterial pneumonia. Vaccines against Haemophilus influenzae type b (Hib), pertussis (whooping cough), measles, varicella (chickenpox), and respiratory syncytial virus (RSV) all contribute to pneumonia prevention in different age groups.

Good hygiene practices are essential for preventing bacterial pneumonia. Washing hands regularly, especially after using the bathroom and before eating, helps remove bacteria that could cause infection. Cleaning and disinfecting frequently touched surfaces reduces the spread of germs. When coughing or sneezing, covering the mouth and nose with a tissue or the inside of the elbow prevents respiratory droplets containing bacteria from spreading to others.

Lifestyle modifications can significantly reduce pneumonia risk. Eating a nutritious diet rich in fruits and vegetables provides the vitamins and minerals needed for a healthy immune system. Regular exercise helps maintain overall health and lung function. Getting adequate sleep allows the body to maintain strong defenses against infection. If you smoke, quitting is one of the most important steps you can take to prevent pneumonia, as smoking damages the lungs' natural protective mechanisms. Avoiding excessive alcohol consumption helps keep the immune system functioning properly. When possible, staying away from people who are sick reduces exposure to infectious bacteria.

Taking good care of chronic medical conditions is another important preventive measure. Well-managed conditions like asthma, diabetes, or heart disease help keep the body's defenses strong. For some individuals, good dental hygiene and regular teeth cleaning may help prevent certain types of pneumonia, as bacteria from the mouth can sometimes travel to the lungs.

How Bacterial Pneumonia Affects the Body

Understanding what happens in the lungs during bacterial pneumonia helps explain why the symptoms occur. When bacteria successfully invade the lungs, they settle into the lung tissue and air sacs. The body immediately recognizes these invaders as foreign and dangerous, triggering an immune response. White blood cells—specialized cells that fight infection—rapidly accumulate in the affected areas of the lung. These cells work to destroy the bacteria, but this battle creates inflammation and produces debris.

As the immune response intensifies, the alveoli—tiny balloon-like sacs where oxygen normally transfers from air into the bloodstream—fill with fluid, white blood cells, dead bacteria, and cellular debris. This accumulation creates the thick mucus or pus that people cough up. With the air sacs filled with fluid instead of air, it becomes much harder for oxygen to pass through the thin walls of the alveoli into the blood vessels that surround them. This is why people with pneumonia may feel short of breath and why their oxygen levels drop.

The inflammation causes the lung tissue to swell and become stiff, making the lungs less flexible and breathing more labored. The infected areas do not expand and contract normally with each breath. Sometimes the inflammation spreads to the pleura—the thin membranes that line the lungs and chest wall. When these membranes become inflamed, they rub against each other during breathing, causing the sharp, stabbing chest pain characteristic of pneumonia. This is why the pain often worsens with deep breaths or coughing.

In severe cases, the infection can spread beyond the lungs. Bacteria may enter the bloodstream, causing sepsis—a dangerous condition where the infection triggers inflammation throughout the entire body. This can lead to organ failure and requires immediate intensive care. The infection may also spread to the space between the lung and chest wall, creating a collection of infected fluid called an empyema. In rare cases, parts of lung tissue may die, forming abscesses or pockets of pus within the lung.

The body's increased metabolic demand during infection explains the fever and sweating. The heart works harder to pump oxygen-depleted blood throughout the body, leading to rapid heartbeat. The breathing centers in the brain sense low oxygen levels and signal the lungs to breathe faster, causing rapid breathing. All of these processes together explain why bacterial pneumonia makes people feel so profoundly ill and exhausted.

Did you know?

  1. The color of mucus coughed up during bacterial pneumonia can actually provide clues about which bacteria is causing the infection—rust-colored suggests Streptococcus pneumoniae, while thick red jelly-like mucus points to Klebsiella bacteria.
  2. Bacterial pneumonia can sometimes cause confusion and altered mental status in older adults even before typical symptoms like fever and cough appear, making it a sneaky and often overlooked presentation.
  3. Pneumonia kills more children under five worldwide than HIV, malaria, and tuberculosis combined, accounting for more than 740,000 deaths annually in this age group alone.

Questions people often ask

This guide is here to help you understand the condition. It does not replace a conversation with your doctor, who knows your situation best.

Clinical trials for Pneumonia bacterial

Recruiting trials first

See all 10 trials →
Quick filters

10 clinical trials in this condition

Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Ampicillin Sodium
  • Sponsor:Bioversys S.A.S.
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Saline
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Cefotaxime
  • Sponsor:Universitair Ziekenhuis Gent
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Amikacin Sulfate
  • Sponsor:Assistance Publique Hopitaux De Paris
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Demerecviridae Bacteriophage Against Klebesiella Pneumoniae (113.073 Bp)
  • Sponsor:Technophage Investigacao E Desenvolvimento Em Biotecnologia S.A.
Countries:ItalyItaly
  • Participants:65+ years
  • Substances:Colecalciferol
  • Sponsor:Azienda Ospedaliero-Universitaria Maggiore Della Carita
See all 10 trials →filters applied: condition = Pneumonia bacterial

Related conditions in the same therapeutic area

Back to all diseases
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).